Basilea Pharmceutica NA buy Quitte
Start price
21.04.16
/
50%
€75.33
Target price
21.10.16
€79.00
Performance (%)
-13.13%
End price
21.10.16
€65.44
Summary
This prediction ended on 21.10.16 with a price of €65.44. The price of Basilea Pharmceutica NA has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.13%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Basilea Pharmceutica NA | - | - | - | - |
| iShares Core DAX® | -0,10 % | 0,54 % | 3,31 % | 53,02 % |
| iShares Nasdaq 100 | 0,59 % | -2,39 % | 30,86 % | 87,45 % |
| iShares Nikkei 225® | -0,05 % | -2,75 % | 60,15 % | 76,07 % |
| iShares S&P 500 | 0,94 % | 1,29 % | 23,99 % | 70,01 % |
Comments by Quitte for this prediction
In the thread Basilea Pharmceutica NA diskutieren
Kampf gegen Hirntumor
Basilea berichtet über Präsentation von Daten zu den klinischen Onkologie-Kandidaten BAL101553 und BAL3833 auf AACR-Tagung
(Laufzeit überschritten)